CXCR4 Expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases

This publication has 21 references indexed in Scilit:

• CXCR4–SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion
  Blood, 2002
• A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma
  The Journal of Immunology, 2001
• Involvement of chemokine receptors in breast cancer metastasis
  Nature, 2001
• Characterization and visualization of [125I] stromal cell-derived factor-1α binding to CXCR4 receptors in rat brain and human neuroblastoma cells
  Journal of Neuroimmunology, 2000
• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
  New England Journal of Medicine, 1999
• Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
  Science, 1999
• The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1
  Blood, 1998
• The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood
  The Journal of Experimental Medicine, 1997
• Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
  Journal of Clinical Oncology, 1993
• Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas
  JNCI Journal of the National Cancer Institute, 1984